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Abstract
Crohn’s disease (CD) is notably characterized by the expansion of visceral fat with small adipocytes expressing a
high proportion of anti-inflammatory genes. Conversely, visceral fat depots in ulcerative colitis (UC) patients have
never been characterized. Our study aims were a) to compare adipocyte morphology and gene expression profile
and bacterial translocation in omental (OM) and mesenteric (MES) adipose tissue of patients with UC and CD, and b)
to investigate the effect of bacterial infection on adipocyte proliferation in vitro. Specimens of OM and MES were
collected from 11 UC and 11 CD patients, processed and examined by light microscopy. Gene expression profiles
were evaluated in adipocytes isolated from visceral adipose tissue using microarray and RTqPCR validations.
Bacteria within adipose tissue were immuno-detected by confocal scanning laser microscopy. Adipocytes were
incubated with Enterococcus faecalis and cells counted after 24h. Morphology and molecular profile of OM and MES
revealed that UC adipose tissue is less inflamed than CD adipose tissue. Genes linked to inflammation, bacterial
response, chemotaxis and angiogenesis were down-regulated in adipocytes from UC compared to CD, whereas
genes related to metallothioneins, apoptosis pathways and growth factor binding were up-regulated. A dense
perinuclear positivity for Enterococcus faecalis was detected in visceral adipocytes from CD, whereas positivity was
weak in UC. In vitro bacterial infection was associated with a five-fold increase in the proliferation rate of OM
preadipocytes. Compared to UC, visceral adipose tissue from CD is more inflamed and more colonized by intestinal
bacteria, which increase adipocyte proliferation. The influence of bacteria stored within adipocytes on the clinical
course of IBD warrants further investigations.
Citation: Zulian A, Cancello R, Ruocco C, Gentilini D, Di Blasio AM, et al. (2013) Differences in Visceral Fat and Fat Bacterial Colonization between
Ulcerative Colitis and Crohn’s Disease. An In Vivo and In Vitro Study. PLoS ONE 8(10): e78495. doi:10.1371/journal.pone.0078495
Editor: Markus M. Heimesaat, Charité, Campus Benjamin Franklin, Germany
Received July 15, 2013; Accepted September 13, 2013; Published October 24, 2013
Copyright: © 2013 Zulian et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by Istituto Auxologico Italiano. Istituto Auxologico Italiano, funder of this study, had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
* E-mail: invitti@auxologico.it
Introduction
The two major forms of chronic inflammatory bowel disease
(IBD), ulcerative colitis (UC) and Crohn’s disease (CD), are
believed to result from interactions between the environment,
genetic predisposition, unbalanced host-commensal microbiota
and a widespread immune defect [1]. However, UC and CD
present distinct pathogenic mechanisms and characteristics [1],
one being the expansion of mesenteric fat surrounding
inflamed intestinal tracts (“creeping fat”), which is typical for CD
and absent in UC.
We have recently demonstrated that, in patients with active
CD, omental (OM) visceral adipose tissue shows the same
inflammatory morphology and molecular profile of creeping fat
(MES) [2]. In addition, we reported that OM adipocytes from
CD patients are smaller than those of normal-weight subjects
and express a higher proportion of anti-inflammatory genes
compared to obese patients. These findings suggest that the
adipocyte undergoes beneficial changes [3] and we
hypothesized that the intra-abdominal fat expansion of CD is a
protective phenomenon aimed at controlling the inflammatory
response and preventing dissemination of intestinal bacteria.
It is worth recalling that gut microbiota and/or their products
have been shown to promote inflammation and determine the
anti-inflammatory response of visceral adipose tissue in obese
patients [4]. Further, bacterial translocation to MES has been
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demonstrated in mice with experimental UC-like colitis and in
humans with CD [5]. Conversely, morphology and molecular
profiles of visceral fat in UC as well as the effects of bacterial
translocation on adipocytes from IBD patients have yet to be
characterized.
Given that intestinal bacteria translocation into intra-
abdominal fat depots of IBD patients may affect both adipocyte
morphology and gene expression, we investigated visceral fat
depots and bacterial translocation in OM and MES from UC
and CD patients. In addition, we analyzed the effects of
intestinal bacteria on visceral adipocyte proliferation in vitro.
Materials and Methods
Patients and specimen collection
Eleven patients with UC (3 severe pancolitis, 3 mild
pancolitis, 2 proctitis and 3 left-sided colitis), and 11 patients
with active CD (7 ileo-colic, 1 colonic and 3 ileal) were recruited
from those referred to surgery for complications. Three UC
patients were hypertensive and two had type 2 diabetes. None
of the CD patients had hypertension and/or diabetes. All CD
and UC patients had discontinued corticosteroids, immuno-
modulators, salicilates or infliximab since at least 2 months.
A fasting blood sample was collected the day before surgery
for measurement of glucose, HDL- and LDL-cholesterol,
triglycerides, fibrinogen and C-reactive protein in all patients.
Adipose tissue specimens were taken from OM and MES
close to the affected intestine. Major efforts were made to
guarantee sterility during tissue collection. Each adipose tissue
specimen was a) fixed in 4% phosphate-buffered formalin for
24h at 4°C, then processed for haematoxylin/eosin and
immunostaining; b) digested with 1 mg/ml collagenase type II
(Sigma, St. Louis, US) for isolation of mature adipocytes for
gene expression arrays and bacterial infection experiments (for
details see below).
The Ethical Committee of the Istituto Auxologico Italiano
approved the study protocol. Written informed consent was
obtained from all patients prior to sample collection.
Biochemical measurements
Serum levels of glucose and lipids were measured using an
automated analyzer (Roche Diagnostics, Mannheim,
Germany). Fibrinogen was measured on citrate plasma with a
clot-rate assay (ACL 200/IL, Instrumentation Laboratory, Milan,
Italy). The sensitivity of this assay is 7.5 mg/dl and the intra-
and inter-assay CVs are 4.8 and 5.2%, respectively. C-reactive
protein was measured by an immuno-turbidimetric assay (CRP
Latex HS, Roche Diagnostics, Mannheim, Germany);
sensitivity is 0.03 mg/l and intra- and inter-assay CVs are 1.3
and 5.7%, respectively.
Morphologic analysis
Adipose tissue samples were formalin-fixed overnight at 4°C,
washed in 1X phosphate buffer saline (PBS) and paraffin
embedded. Sections were cut at 5 µm thickness and then
stained with haematoxylin and eosin or used for bacterial
immunostaining (see later). Adipocyte cell diameter was
assessed by light microscopy on 5 randomly selected sectional
areas (10X, Leica DMR, Wetzlar, Germany) and at least 200
cells were measured using an image analysis system (Leica
QWin image analysis and processing).
Isolation of human adipocytes
Immediately after removal, a fragment of adipose tissue was
cut into small pieces and digested with 1 mg/ml collagenase
type II (Sigma, St. Louis, US) for at least 1 hour at 37°C with
horizontal agitation. Digested tissue was filtered first through
sterile gauze and then through 100 µm nylon filter (BD
Bioscience 1 Becton Drive Franklin Lakes, New Jersey, USA).
Filtrates were centrifuged at 500xg and floating adipocytes
washed in PBS, collected and stored in TRIzol (Invitrogen,
Carlsbad, CA, USA) until RNA extraction.
The purity of adipocytes was verified using RNA markers of
macrophage [(MCP-1, CD206 and CD163)] and adipocyte
[fatty acid binding protein (FABP4), perilipin (PLIN), leptin
(LEP), peroxisome proliferator-activated receptor gamma
(PPARG)] cells.
RNA preparation and cDNA synthesis
The RNA from isolated adipocytes was extracted using
TRIzol plus RNA Purification Kit (Invitrogen Corporation,
Jefferson City, US) as per manufacturer’s instructions. RNA
concentrations were quantified by spectrophotometer and RNA
integrity verified by agarose gel electrophoresis.
Microarray analysis and functional annotations
Gene expression profiles were analyzed using the Human
HT-12 v3 BeadChips whole-genome gene expression direct
hybridization assay (Illumina, San Diego, CA), as previously
described [2]. Microarray experiments were performed on
duplicates of 4 different pools of RNAs extracted from
adipocytes isolated from OM and MES of UC patients (n=5)
and CD patients (n=5), respectively (NCBI’s GEO repository,
accession number GSE46754).
Prioritized differentially expressed gene lists obtained by
Genome Studio software (Illumina) were uploaded onto DAVID
(Database for Annotation, Visualization, and Integrated
Discovery) [6] and annotated automatically. Microarray data
were MIAME compliant [7].
Validations of microarray data by Real Time
quantitative PCR (RTqPCR)
Copy DNAs obtained by reverse-transcription with
SuperScript III (Invitrogen, Carlsbad, CA) from 500 ng total
RNA were used for quantitative gene expression. The following
Assay-on-Demand probes (Applied Biosystems by Life
Technologies Italia, Monza, Italy) were used: interleukin 6 (IL6),
tumor necrosis factor alpha (TNFA), monocyte chemoattractant
protein 1 (MCP1), metallothionein 1G (MT1G) and 1E (MT1E),
lipopolysaccharide-binding protein (LBP) and defensin beta 1
(DEFB1). Human ribosomal protein LP0 (RPLP0) was used as
housekeeping gene. The data were analysed using the SDS v.
3 software (Software Diversified Systems, Spring Lake Park,
MN). Quantification of unknown samples was performed by
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2^deltadeltaCt (i.e., target gene mRNA is normalized to RPLP0
expression by subtracting the Ct for the housekeeping gene
from the Ct for the gene of interest) and expressed as arbitrary
units (AU).
In vitro effect of bacterial infection on adipocyte
proliferation
Fragments of OM collected from 2 UC and 2 CD patients
were digested with 1 mg/ml collagenase type II (Sigma, St.
Louis, US) as previously described [2]. Stromal vascular
fraction cells (SVF) were isolated by centrifugation and cultured
in 1:1 Ham’s F12/DMEM (Invitrogen Corporation, Jefferson
City, US) supplemented with 10% decomplemented Fetal
Bovine Serum (FBS) (Sigma, St. Louis, US), penicillin,
streptomicin and amphotericin B. At sub-confluence, cells were
starved for 3h in Ham’s F12/DMEM 1%FBS without antibiotics
and then infected for 24h with 0.001 McFarland (=100.000
CFU/ml) Enterococcus faecalis (Lyfocults, Biomerieux Inc.,
Durham, NC) in the latter medium. Enterococcus faecalis was
chosen because it is a common cause of systemic infection
and lethality in humans [8]; length of incubation and bacterial
concentration allowing greater cell survival and viability were
chosen. In vitro infections with Escherichia coli and
Staphylococcus aureus were not suitable due to the increased
adipose cell death.
After 24h infection with Enterococcus faecalis, cells were
repeatedly washed with PBS and counted on Beckmann cell
counter (Z2 coulter counter, Beckman Coulter, Inc.). Infection
experiments were also performed on in vitro differentiated
adipocytes, i.e. after 10-day differentiation with Stempro
adipogenesis differentiation kit (Life Technologies Italia,
Monza, Italy). After bacterial infection, intracellular triglyceride
storage levels were assessed by AdipoRed staining, according
to the manufacturer’s procedure (Lonza, Milan, Italy).
Confocal microscopy
Sections (5 µm) of MES and OM from UC and CD patients
were deparaffinised and hydrated, permeabilized for 10
minutes with PBS containing 0.3% triton X-100 (PBST) and
then incubated for 30 minutes with 1% Bovine Serum Albumin
(BSA) in PBST at room temperature (RT). Sections were then
incubated for 1h at RT with a polyclonal antibody raised against
Enterococcus faecalis (1:500 dilution, Ab-cam, Cambridge, UK)
in 1% BSA-PBST. Slides were washed thrice in PBST and
incubated for 30 minutes at RT with a secondary antibody
(1:200, Alexa Fluor 568 goat anti-rabbit antibody coupled with
ThRed, Life Technologies Italia, Monza, Italy). After three
washes in PBST, slides were mounted in DAPI-containing
mounting medium (Ab-cam Cambridge, UK) and visualized on
a Nikon Eclipse Ti inverted confocal microscope system (Nikon
Instruments Europe B.V., Amsterdam, NL). Images were
captured and analysed by Nis Elements software (Nikon
Instruments Europe B.V., Amsterdam, NL).
Statistical analyses
The “Detection Score”, i.e. Z-value of a gene relative to Z-
value of negative controls, was used to determine expression
levels using Illumina Genome Studio software. Genes with
detection P-value <0.05 were considered to be expressed.
Illumina data was normalized using a cubic spline function.
Genes with a nominal P-value ≤0.05 were considered
statistically significant. Spearman’s correlation was used to
evaluate relationships between average signal detection (AVG)
of selected genes in microarray studies and mRNA expression
levels at RTqPCR.
Differences between groups were calculated using Student’s
t test or Mann-Whitney’s test, as appropriate. Analyses were
performed using Graphpad Prism software and SPSS 19




Clinical characteristics of patients with IBD are shown in
Table 1. Compared to CD patients, UC patients were older,
presented higher levels of HDL cholesterol and lower levels of
triglycerides and inflammatory markers.
Morphological and morphometric adipocyte
characterization
OM and MES samples were observed at light microscopy.
Figure 1A shows the morphology of OM and MES
compartments in one representative UC and CD patient,
respectively. Both fat depots appeared to be less inflamed in
UC than in CD. In UC, OM was more inflamed and fibrotic than
MES. OM adipocytes were significantly smaller than those in
MES from both IBD patients (Figure 1B).
Molecular signature of adipocytes isolated from OM
and MES
In order to avoid contamination by inflammatory cells, gene
expression was studied in adipocyte cell fractions from OM and
MES from UC and CD patients. Clustering of global gene
expression of OM and MES from UC and CD patients is shown
in Figure 2A. The gene expression profile of OM adipocytes
Table 1. Clinical and biochemical characteristics of patients
with UC and CD.
 UC n=11 CD n=11
Male/Female 6/5 5/6
Age, years 51.8±14.3* 41.0±10.6
BMI, kg/m2 23.6±3.9 21.9±3.7
Fasting glucose, mg/dl 96.4±43.1 93.0±17.8
Waist circumference, cm 78.7±10.7 79.4±13.1
HDL cholesterol, mg/dl 45.1±15.2 * 33.3±7.0
LDL cholesterol, mg/dl 79.1±26.1 76.4±19.1
Triglycerides, mg/dl 95.2±41.1 123.4±36.2
Fibrinogen, mg/dl 378.0±61.7 * 498.4±99.6
CRP, mg/dl 1.6±1.3 3.1±4.2
*. P<0.05 vs. CD. Data are expressed as mean ± SD.
doi: 10.1371/journal.pone.0078495.t001
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from the two IBD clustered together whereas MES adipocytes
formed separate branches.
Two independent differential expression analyses were
performed: 1) comparison between OM adipocytes from UC
and CD and 2) comparison between MES adipocytes from UC
and CD. The proportion of genes differentially expressed
ranged between 11 and 14% for each analysis (Figure 2B).
Figure 2C shows genes down- and up-regulated in visceral fat
depots from UC and CD. Comparison of OM adipocytes
derived from the two IBD demonstrated that genes related to
metallothioneins and apoptosis pathways were up-regulated
and genes linked to inflammation, chemotaxis and
angiogenesis were down-regulated in UC compared to CD.
Genes linked to bacterial response and inflammation (listed in
Table 2) were likewise down-regulated in MES adipocytes from
UC compared to CD, whereas genes related to growth factor
Figure 1.  Morphological and morphometric
characterization of adipose tissue from UC and CD
patients.  A. Haematoxylin-eosin staining of omental (OM) and
mesenteric adipose (MES) tissue sections from one
representative ulcerative colitis (UC) and Crohn's disease (CD)
patient. Magnification is 10X. B. Mean adipocyte size from
different adipose tissue depots from 11 UC and 11 CD patients.
Data are expressed as means ± SE, *P<0.05 between OM and
MES in UC and CD patients.
doi: 10.1371/journal.pone.0078495.g001
binding were up-regulated. About half (13/29) of bacterial
response genes, down-regulated in MES adipocytes from UC,
were also down-regulated in OM adipocytes.
Comparison of microarray patterns in OM adipocytes from
UC with results obtained in healthy controls in a previous study
[2], revealed that genes related to apoptosis and inflammatory
response were up-regulated while those related to metabolic
pathways were down-regulated (Figure S1).
Microarray signals were validated by RTqPCR of selected
genes, chosen among those differentially expressed in adipose
tissue from UC and CD patients. In agreement with microarray
results, MT1G and MT1E were more expressed and LBP less
expressed in UC OM than in CD OM (Figure 3A); conversely,
TNFA, LBP and DEFB1 were less expressed in UC MES than
in CD MES (Figure 3B).
Detection of intestinal bacteria in visceral fat from IBD
patients and effects of bacterial infection on adipocyte
proliferation rate
Confocal microscopy demonstrated a dense perinuclear
fluorescent stain for Enterococcus faecalis in MES and OM
from CD patients, whereas the same adipose tissue depots
were only weakly stained in UC specimens (Figure 4).
Infection of OM preadipocytes with Enteroccocus faecalis
induced a five-fold increase in proliferation rate compared to
non-infected cells (Figure 5). In differentiated adipocytes,
infection nevertheless induced a two-fold increase in
proliferation rate (Figure 5), accompanied by a 20 % decrease
in intracellular lipid content (data not shown).
Discussion
In this study, we provide the first morphological and
molecular characterization of visceral fat depots from UC
patients. We demonstrate that visceral fat depots from UC
patients display less inflammatory features than those from CD
patients, both as regards tissue morphology and adipocyte
molecular profile. These results are in keeping with the more
severe disruption of intestinal barrier, which characterizes CD
patients. Visceral adipose tissue inflammation may be driven
by intestinal bacteria translocation, possibly proportional to the
severity of intestinal lesions. Down-regulation of genes linked
to the bacterial response in UC adipocytes tallies with the lower
bacterial load in visceral fat from UC compared to CD, whereas
up-regulation of genes related to growth factor binding may
contribute to the absent fat expansion in UC. The greater
bacterial load in visceral fat depots from CD compared to UC
might also explain the distinctive development of intra-
abdominal hyperplasia in CD. To verify this hypothesis, we
infected preadipocytes and differentiated adipocytes with a
“non-cytotoxic” load of Enterococcus faecalis in vitro and
observed an increase in preadipocyte proliferation rate.
Further, proliferation was stimulated also in mature adipocytes,
which are less prone to proliferate, with the expected
concomitant reduction of intracellular lipid content. This finding
agrees with the well-known adipocyte plasticity [9] and
suggests that mature adipocytes are able to “de-differentiate”
(i.e. decrease their intracellular lipid content) and activate
Adipocyte Biology, Gut Microbiota and IBD
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proliferative rather than lipogenic pathways during bacterial
challenge. In fact, adipocyte cellular differentiation is no longer
believed to be irreversible and we herein provide the
demonstration that, in conditions such as bacterial load,
adipocytes may change their phenotype and reconvert into
stromal-vascular cells [9].
Another interesting finding is that bacterial translocation does
not target the MES only but may spread to the OM, a depot
which is not in direct contact with intestinal lesions. This finding
agrees with experimental models of colitis which have shown
that gut bacteria translocate from intestinal epithelial cells to
mesenteric lymph nodes, blood and peripheral organs including
visceral fat [10]. Further, clinical conditions associated with
altered gut permeability, e.g. type 2 diabetes, have been
associated with increased circulating bacterial DNA both in
mice and men [11,12].
A recent study has demonstrated that bacterial translocation
to mesenteric lymph nodes and fat is more frequent in patients
with CD compared to patients with colorectal cancer,
diverticulitis or UC [5]. Our results show for the first time that
the extent of bacterial translocation to MES and OM is much
greater in CD than in UC.
The typical perinuclear cellular positivity observed in almost
all samples analyzed by confocal microscopy, enabled us to
exclude artifacts and cross-contamination during surgical tissue
collection and demonstrates that bacteria invade adipocytes in
addition to macrophages. Further demonstration that
adipocytes may sequester bacteria was obtained in animal and
human studies reporting that Rickettsia prowazekii and
Mycobacterium tuberculosis survive in non-replicating state in
adipocytes during disease dormancy [13,14]. It may therefore
be postulated that adipose tissue acts as a "reservoir" for
recrudescent disease caused by dormant infection with enteric
commensal bacteria. Within adipocytes, bacteria may be
shielded from antibiotics, thus contributing to the variable
efficacy of antibiotic therapy in IBD [15].
In conclusion, visceral adipose tissue depots from patients
with UC and CD differ significantly in their morphology and
molecular profile. The presence of intestinal bacteria in visceral
adipocytes and their effect on adipocyte de-differentiation and
Figure 2.  Gene expression analysis of isolated adipocytes from UC and CD patients.  A. Clustering of global gene expression
in omental adipose tissue (OM) and mesenteric adipose tissue around the involved intestinal tract (MES) in ulcerative colitis (UC)
and Crohn's disease (CD) patients.
B. Numbers of detected genes and percentage of differentially expressed genes in UC OM vs. CD OM and in UC MES vs. CD MES.
Details of down- and up-regulated genes are indicated.
C. Functional annotations of genes differentially expressed in UC OM vs. UC MES, in UC OM vs. CD OM and in UC MES vs. CD
MES. GO: Gene Ontology-Biological Process. The first five most significant clusters of up- and down-regulated genes are shown.
doi: 10.1371/journal.pone.0078495.g002
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Table 2. List of bacterial response genes in MES and OM adipocytes from UC or CD.
SYMBOL MES UC/MES CD DiffScore MES UC/MES CD FC OM UC/OM CD DiffScore OM UC/OM CD FC DEFINITION
CCL20 -348.14 0.23 -113.36 0.48 chemokine (C-C motif) ligand 20
SERPINA1 -155.94 0.24 -42.26 0.44 serpin peptidase inhibitor, clade A member 1
IL1B -348.14 0.31 -125.97 0.56 interleukin 1, beta
DEFB1 -348.14 0.34 -290.68 0.20 defensin, beta 1
LYZ -102.98 0.35 -32.27 0.65 lysozyme
LBP -83.87 0.37 -94.19 0.59 lipopolysaccharide binding protein
IL27RA -20.95 0.39 -32.46 0.40 interleukin 27 receptor, alpha
TNF -348.14 0.47 -181.44 0.42 tumor necrosis factor (TNF superfamily, member 2)
CD14 -209.08 0.58 -79.25 0.65 CD14 molecule (CD14), transcript variant 1
PLA2G2A -13.91 0.68 -61.87 0.52 phospholipase A2, group IIA
CCL5 -111.47 0.69 -23.34 0.58 chemokine (C-C motif) ligand 5
HIST1H2BK -53.20 0.76 -18.13 0.82 histone cluster 1, H2bk
TIMP4 -17.87 0.81 -58.52 0.66 TIMP metallopeptidase inhibitor 4
The Differential score (DiffScore) obtained by Genome Studio software (Illumina) is indicated. A differential score <-13 (i.e. P<0.05) was considered statistically significant.
For each gene, the fold change (FC) is indicated.
doi: 10.1371/journal.pone.0078495.t002
Figure 3.  Validation of microarray data by Real Time quantitative PCR.  A. Expression of metallothionein 1G (MT1G),
metallothionein 1E (MT1E), lipopolysaccharide-binding protein (LBP) mRNA in omental adipose tissue (OM) from Crohn's disease
(CD) and ulcerative colitis (UC) patients.
B. Expression of tumor necrosis factor alpha (TNFA), lipopolysaccharide-binding protein (LBP) and defensin beta 1 (DEF1B) in CD
and UC MES.
Data were normalized to human ribosomal protein LP0 (RPLP0) and are expressed as arbitrary units (AU) ± SE, *P<0.05.
doi: 10.1371/journal.pone.0078495.g003
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proliferation may explain adipocyte hyperplasia in creeping fat.
The role of bacteria stored into visceral fat on the clinical
course of IBD deserves further investigation.
Figure 4.  Detection of intestinal bacteria in visceral fat from UC and CD patients.  Fluorescent immunodetection of
Enterococcus faecalis (red) in omental adipose tissue (OM) and mesenteric adipose tissue (MES) from 1 representative ulcerative
colitis (UC) and 1 Crohn's disease (CD) patient by confocal microscopy. Magnification is 40X. Nuclei are counterstained in blue
(DAPI, 4',6-diamidin-2-fenilindolo).
doi: 10.1371/journal.pone.0078495.g004
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Figure 5.  Effects of bacterial infection on adipocyte
proliferation rate.  Mean cell number ± SE of omental
preadipocytes (SVF) and 10-day differentiated adipocytes
(ADIPO) from 4 patients (2UC and 2CD) after 24h incubation
with (SVF EF and ADIPO EF) or without (SVF C and ADIPO C)
0.001 McFarland Enterococcus faecalis. *P<0.05.
doi: 10.1371/journal.pone.0078495.g005
Adipocyte Biology, Gut Microbiota and IBD
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Supporting Information
Figure S1.  UP and DOWN-regulated genes in UC versus
control omental adipocytes. Gene Ontology (GO) Biological
Process of the first five clusters of up-regulated and down-
regulated genes in omental adipocytes (OM) of ulcerative
colitis patients (UC) compared to controls. Genes belonging to
each category are shown.
(TIF)
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